User menu

Breath C-14o2 After Intravenous Administration of [c-14] Aminopyrine in Liver-diseases

Bibliographic reference Pauwels, Stanislas ; Geubel, André ; Dive, Charles ; Beckers, Christian. Breath C-14o2 After Intravenous Administration of [c-14] Aminopyrine in Liver-diseases. In: Digestive Diseases and Sciences, Vol. 27, no. 1, p. 49-56 (1982)
Permanent URL http://hdl.handle.net/2078.1/57733
  1. Hepner GW, Vesell ES: Quantitative assessment of hepatic function by breath analysis after oral administration of14C-aminopyrine. Ann Intern Med 83:632?638, 1975
  2. Lewis KO, Nicholson G, Lance P, Paton A: Aminopyrine breath test in alcoholic liver disease and in patients on enzyme-inducing drugs. J Clin Pathol 30:1040?1043, 1977
  3. Galizzi J, Long RG, Billing BH, Sherlock S: Assessment of the [14C]aminopyrine breath test in liver disease. Gut 19:40?45, 1978
  4. Garlisle R, Galambos JT, Warren WD: The relationship between conventional liver tests, quantitative function tests, and histopathology in cirrhosis. Dig Dis Sci 24:358?362, 1979
  5. Bircher J, Küpfer A, Gikalov I, Preisig R: Aminopyrine demethylation measured by breath analysis in cirrhosis. Clin Pharmacol Ther 20:484?492, 1976
  6. Hepner GW, Vesell ES: Aminopyrine disposition: Studies on breath, saliva, and urine of normal subjects and patients with liver disease. Clin Pharmacol Ther 20:654?660, 1976
  7. Noordhock J, Dees J, Savenije-Chapel EM, Wilson JHP: Output of14CO2 in breath after oral administration of [14C-methyl]aminopyrine in man: Its relation with aminopyrine clearance. Congrès National de la Société Belge des Sciences Pharmaceutiques et de la Division de Chimie Thérapeutique de la Société Chimique de Belgique. Edited by Société Belge des Sciences Pharmaceutiques. Anvers, 1977, p 49
  8. Bircher J, Platzer R, Gikalov I, Küpfer A, Preisig R: Aminopyrine breath test for evaluation of liver function. How to analyse the14CO2 data. Radioaktive Isot Klin Forschung 12:347?356, 1976
  9. Zieve L, Hill E: An evaluation of factors influencing the discriminative effectiveness of a group of liver function tests. II Normal limits of 11 representative hepatic tests. Gastroenterology 28:766, 1955
  10. Branch RA, Herbert CM, Read AE: Determinants of serum antipyrine half-lives in patients with liver disease. Gut 14:569?573, 1973
  11. Andreasen PB, Ranck L, Statland BE, Tygstrup N: Clearance of antipyrine-dependence of quantitative liver function. Eur J Clin Invest 4:129?134, 1974
  12. Brodie BB, Axelrod J: The fate of aminopyrine (pyramidon) in man and methods for the estimation of aminopyrine and its metabolites in biological material. J Pharmacol Exp Ther 99:171?184, 1950
  13. La Du BN, Gaudette L, Trousoe N, Brodie BB: Enzymatic dealkylation of aminopyrine (Pyramidon) and other alkylamines. J Biol Chem 214:741?752, 1955
  14. Lauterburg BH, Bircher J: Hepatic microsomal drug metabolizing capacity measuredin vivo by breath analysis. Gastroenterology 65:A-32/556, 1973
  15. Lauterburg BH, Bircher J: Expiratory measurement of maximal aminopyrine demethylationin vivo. Effects of phenobarbital, partial hepatectomy, porto-caval shunt and bile duct ligation in the rat. J Pharmacol Exp Ther 196:501?509, 1976
  16. Hepner GW, Vesell ES: Assessment of aminopyrine metabolism in man by breath analysis after oral administration of14C-aminopyrine. Effects of phenobarbital, disulfiram and portal cirrhosis. N Engl J Med 291:1384?1388, 1974
  17. Hepner GW, Vesell ES: Aminopyrine metabolism in the presence of hyperbilirubinemia due to cholestasis or hepatocellular disease. Combined use of laboratory tests to study disease-induced alterations in drug disposition. Clin Pharmacol Ther 21:620?626, 1977
  18. Bircher J, Gikalov I: The aminopyrine breath test, a noninvasive procedure to measure the functional reserve of the liver.In Current Views in Gastroenterology. V Varro, GA Balint (eds). Budapest, Hungarian Society of Gastroenterology, 1977, pp 621?626
  19. Pauwels S, Geubel AP, Beckers C: Breath analysis after intravenous administration of C-14-aminopyrine in liver disease. J Nucl Med 21:P76, 1980
  20. Saunders JB, Lewis KO, Paton A: Early diagnosis of alcoholic cirrhosis by the aminopyrine breath test. Gastroenterology 79:112?114, 1980
  21. Soloway RD, Baggenstoss AH, Schoenfield LJ, Summerskill WHJ: Observer error and sampling variability tested in evaluation of hepatitis and cirrhosis by liver biopsy. Am J Dig Dis 16:1072?1086, 1971
  22. Remmer H, Bolt HM, Bannasch P, Popper H (eds): Primary Liver Tumors. Lancaster, MTP Press, 1978
  23. Piken E, Hepner GW: Decreased hepatic microsomial reserve in patients with cirrhosis. J Lab Clin Med 94:947?954, 1979
  24. Madison FW, Squier TL: The etiology of primary granulocytopenia (agranulocytic angina). J Am Med Assoc 102:755?759, 1934
  25. Pisciotta AV: Immune and toxic mechanism in drug-induced agranulocytosis. Semin Hematol 10:279?310, 1973
  26. Palva IP, Mustala OO: Drug induced agranulocytosis with special reference to aminophenazone. 1. Adults. Acta Med Scand 187:109?115, 1970